Management Committee Approval Sample Clauses

Management Committee Approval. Except for matters expressly specified in this Agreement as requiring a Supermajority Vote of the Management Committee, any action required or permitted to be taken by the Management Committee may be taken upon the affirmative approval, at a duly called meeting or, upon ten (10) calendar days prior notice to all Representatives, by written consent in lieu of a meeting, of Representatives appointed by Members representing more than 50% of the Percentage Interests of all Members (a "Majority Vote"). Unless authorized to do so by this Agreement or by a Majority Vote of the Management Committee and except for the power delegated to the Manager pursuant to Section 8.2, no Member, attorney-in-fact, officer, employee or other agent of the Company shall have any power or authority to bind the Company in any way.
AutoNDA by SimpleDocs
Management Committee Approval. If the Development Manager has recommended to the Management Committee that the Project be commenced, and the conditions set forth above in Section 6.1 have been satisfied, the Management Committee may approve commencement of the Project by a Level B Vote of the Management Committee, subject to the subsequent election of Participants to participate in one hundred percent (100%) of the ownership in the Project pursuant to the procedures set forth in the provisions of Section 6.3 below. If one hundred percent (100%) of the ownership interest in the Project are not subscribed, the Project shall not be deemed approved by the Management Committee.
Management Committee Approval. The Management Committee of Earlychildhood has taken all actions necessary under the California Limited Liability Company Act required for the approval of the Transactions and no other approval under any California anti-takeover statute or regulation applicable to Earlychildhood is required in connection with the consummation of the Transactions. No "fair price," "moratorium," "control share acquisitions" or other similar anti-takeover statute or regulation is applicable to Earlychildhood or (by reason of Earlychildhood's participation therein) this Agreement, the Contribution or the Transactions.
Management Committee Approval. The Management Committee may approve a Financing Commitment at any time. Beginning no later than the date upon which the Company has entered into Significant Offtake Agreements pursuant to which an aggregate of sixty-five percent (65%) of the total output of Capacity or Energy from the Facility will be sold for terms of no less than fifteen (15) years, the Members agree (a) to work together to develop a plan for Project Financing and (b) diligently to jointly pursue and obtain Financing Commitments to implement such plan.
Management Committee Approval. A Transfer by an Owner that has been approved by the Management Committee;
Management Committee Approval. No sale, exchange, transfer, or assignment of Units may be made by a Member unless such sale, exchange, transfer or assignment has been approved by the Management Committee.
Management Committee Approval. Notwithstanding any other provision of this Agreement other than Sections 7.2 and 7.3 hereof, a Transfer of a Member's Interest may not be made unless it is the opinion of the Management Committee and counsel for the Company (i) that such Transfer would not cause the Company to lose its status as a partnership for federal income tax purposes, or (ii) that 14 18 such Transfer would not violate any provision of federal or state securities laws applicable to the Company or the Interest therein.
AutoNDA by SimpleDocs
Management Committee Approval. The Bank shall have received appropriate resolutions of the Management Committee of Borrower approving the transactions described in this Agreement;

Related to Management Committee Approval

  • Management Committee The Members shall act collectively through meetings as a "committee of the whole," which is hereby named the "Management Committee." The Management Committee shall conduct its affairs in accordance with the following provisions and the other provisions of this Agreement:

  • Board of Directors Approval Seller shall have received the approval of its board of directors to the transactions contemplated by this Agreement.

  • Board of Director Approval This Agreement shall have been approved by the Board of Directors of Acquirer.

  • Board Approval No reimbursement shall be paid to the Investment Adviser pursuant to this provision in any fiscal year, unless the Trust's Board of Trustees has determined that the payment of such reimbursement is appropriate in light of the terms of this Agreement. The Trust's Board of Trustees shall determine quarterly in advance whether any portion of the Reimbursement Amount may be paid to the Investment Adviser in such quarter.

  • Advisory Committee The Settling State shall designate an Opioid Settlement Remediation Advisory Committee (the “Advisory Committee”) to provide input and recommendations regarding remediation spending from that Settling State’s Abatement Accounts Fund. A Settling State may elect to use an existing advisory committee or similar entity (created outside of a State-Subdivision Agreement or Allocation Statute); provided, however, the Advisory Committee or similar entity shall meet the following requirements:

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Transition Committee 8.1.0 A transition committee comprised of the employee representatives and the employer representatives, including the Crown, will be established by January 31, 2016 to address all matters that may arise in the creation of the Trust.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • Plenary authority of the Board of Trustees The Sub-Adviser and Adviser both acknowledge that the Fund is a mutual fund that operates as a series of the Trust under the authority of the Board of Trustees.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!